Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
Titel:
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
Auteur:
Beyrouti, Alexandre Deuze, Juliette Fontas, Eric Foureau, Aurore Barbarot, Sébastien Aubert, Hélène Bernier, Claire Le Moigne, Marie Passeron, Thierry Boukari, Feriel Garnier, Margaux Jachiet, Marie Tetart, Florence Seneschal, Julien Toussaint, Clémentine Mahé, Emmanuel Leleu, Camille Regnault, Marie Masson Pasteur, Justine Nosbaum, Audrey Badaoui, Antoine Fougerousse, Anne-Claire Pralong, Pauline Viguier, Manuelle Droitcourt, Catherine Abasq, Claire Mallet, Stéphanie Raison-Peyron, Nadia Staumont-Sallé, Delphine Hubiche, Thomas
Verschenen in:
The journal of allergy and clinical immunology. In practice